Ruminants

What's New?

Partners in Reproduction Website

A communication and information campaign from Intervet, the global leader in reproduction management in ruminants. We strive to bring to our clients not only the widest range of reproductive hormones, antibiotics and vaccines against diseases that impair reproductive efficacy in ruminants but also provide extensive technical service and information.

Bovilis® IBR marker

Towards the goal of achieving IBR eradication, vaccination plays a very important role. Bovilis® IBR marker live, with its unique single-shot vaccination regime, and Bovilis® IBR marker inac have proven to be the best tools to both control IBR and achieve its eradication.

Date	Description
29 Apr 2008	Intervet/Schering-Plough Animal Health outlines strength of the combination First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countriesBoxmeer, April 29, 2008 – Intervet/Schering-Plough Animal Health released the first batch of Bovilis BTV8 vaccine ...
29 Feb 2008	Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccine Angers, February 29, 2008 – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.Intervet is working ...
16 Jan 2008	Intervet has developed Bluetongue vaccine Boxmeer, January 16, 2008 – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine ...
2 Nov 2007	Yearly Conference of Dairy Cattle Reproduction Council A second yearly convention of the US Dairy Cattle Reproduction Council took place in Denver, Colorado on 2nd -3rd November 2007. The Dairy Cattle Reproduction Council was formed as an organization gathering ...
29 Jun 2007	Intervet opens formulation and filling unit at its international competence center for Foot and Mouth Disease Today, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially ...
21 Aug 2006	Intervet Receives FDA Approval for Zilmax Intervet’s U.S. business (Intervet Inc.) has received approval from the U.S. Food and Drug Administration (FDA) for Zilmax (zilpaterol hydrochloride), a product designed to improve production efficiencies ...
15 Dec 2005	Reducing animal testing Clostridial bacteria produce toxins that cause a range of diseases in animals. Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ...
25 Jun 2005	Corporate Social Responsibility - Intervet India Introduction In line with Intervet’s Business Principles and HSE programs, the Intervet India CSR Committee has undertaken various social projects. These projects are focused on children and women, below ...
25 Jun 2005	FFA (Future Farmers of America) – Intervet Inc. US “Premier leadership, personal growth and career success” are some of the goals of the FFA Organization, formerly known as the Future Farmers of America. At Intervet Inc. we applaud those goals, and hope ...
25 Jun 2005	Modern technology for animal and consumer safety - Intervet International With growing concern, we all read about outbreaks of highly infectious animal diseases, such as Foot and Mouth. Usually, these outbreaks result in millions of animals being killed in order to keep the ...
11 Oct 2001	Product news FMD Marker Intervet announces FMD marker test Intervet, Akzo Nobel’s animal healthcare business, has developed a test for Foot and Mouth Disease (FMD) to indicate virus infection in vaccinated animals. The ...